Best Neurologists for Multiple Sclerosis (MS) Management in Mumbai, India

This page lists 1 multiple sclerosis (ms) management doctor in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

Quick answer

This page lists 1 multiple sclerosis (ms) management doctor in Mumbai, India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.

About Multiple Sclerosis (MS) Management doctors in Mumbai, India

This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.

Multiple Sclerosis (MS) Management doctors

Image not available Featured

Dr. Prashant Makhija

MBBS, MD (General Medicine), DM (Neurology), Certified Sleep Disorders Specialist
Consultant Neurologist, Neurology · Specialty: Neurologist
Wockhardt Hospital Mumbai, India10+ Years experience
Why consider this doctor?
  • 10+ years of experience in Neurologist
  • Currently serving as Consultant Neurologist at Wockhardt Hospitals, South Mumbai and Mumbai Central.
  • Has managed over 10,000 patients across a broad spectrum of neurological conditions throughout his career.
Expertise & Procedures
  • Stroke Treatment & Acute Neurological Intervention
  • Stroke Rehabilitation & Recovery Planning
  • Epilepsy Diagnosis & Medical Management
  • Drug-Resistant Epilepsy Evaluation & Care
  • Migraine & Chronic Headache Treatment
View all procedures →
Neurologist Experience: 10+ YearsHospital Affiliation: Wockhardt HospitalHospital accreditation: NABH, JCI

Hospitals where these doctors practise

Wockhardt Hospital🇮🇳 Mumbai, India
Starting from$2,500

Wockhardt Hospital

Est. 2014
NABHNational Accreditation Board for Hospitals & Healthcare Providers accreditationJCIJoint Commission International accreditation
Multiple Sclerosis (MS) ManagementNeurologyCardiac SurgeryCardiology
1+
Doctors for Multiple Sclerosis (MS) Management
4.4
30 reviews
350+
Beds
12+
Years Since Founded
Dr. Prashant Makhija

Why consider treatment in India?

Many international patients consider India for multiple sclerosis (ms) treatment for several reasons, including:

More affordable estimates

Competitive indicative costs compared with many other countries, for similar clinical standards.

Internationally accredited hospitals

Hospitals experienced in treating international patients.

Experienced specialists

Doctors who regularly manage similar cases.

Care coordination support

A team to help with planning, medical translation and follow-up.

About the Procedure

What is Multiple Sclerosis (MS) Management?

Multiple Sclerosis (MS) Management is a comprehensive, neurologist-led program combining advanced diagnostics, disease-modifying therapies (DMTs), acute relapse treatment, and rehabilitation to slow disease progression, reduce relapse frequency, and preserve neurological function. Since MS has no single cure, treatment plans in India are individualized based on disease subtype (relapsing-remitting, secondary/primary progressive) and severity. Leading Indian neuroscience centers offer world-class MRI diagnostics, immunotherapy infusions, and in select aggressive cases, autologous stem cell transplantation, all at a fraction of Western costs.

Who may be considered?

Multiple Sclerosis (MS) Management may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.

How does it work?

Includes complete neurological evaluation, MRI-based confirmation, and initiation of injectable, oral, or infusion-based DMTs tailored to the patient's MS subtype.

3 approaches available for this procedure:

Diagnostic Workup & Disease-Modifying Therapy (DMT) Initiation

Most Common

Includes complete neurological evaluation, MRI-based confirmation, and initiation of injectable, oral, or infusion-based DMTs tailored to the patient's MS subtype.

Comprehensive Investigations

Estimated cost: $500 - $1,500

Brain and spine MRI with contrast, CBC, liver and kidney function tests, JC virus antibody test, TB screening, ECG, evoked potential studies, lumbar puncture (if needed)

Treatment / Procedure Estimate

Estimated cost in India: $3,000 - $6,500

Stay in India

Pre-procedure stay (outside hospital): ~2-3 days
Hospitalisation: ~3-5 days
Recovery period (outside hospital): ~7 days recommended
Total stay: approx 10-14 days

Usually Included in Hospital Package

  • Neurologist consultations
  • MRI and lab diagnostics
  • First DMT dose administration/infusion
  • Nursing and monitoring during hospital stay
  • Care coordination and case management

Usually Not Included

  • Ongoing DMT medication costs after initiation
  • Long-term follow-up MRIs
  • Airfare and visa expenses
  • Accommodation for extended stay
  • Physiotherapy/rehabilitation sessions

Recovery and follow-up

Most patients can resume light daily activities within a week of DMT initiation or relapse treatment, while AHSCT patients require several weeks of immune recovery with strict infection precautions and phased physiotherapy. Regular neurologist follow-up and periodic MRI monitoring are essential to track disease activity long-term.

Risks

DMTs and steroid therapy carry risks of infection, liver/kidney strain, and infusion reactions, while AHSCT carries additional risks of severe infection, bleeding, and rare treatment-related mortality due to immune suppression. All patients are closely monitored throughout treatment to minimize these risks.

Alternatives

Alternatives include conservative symptom-focused management with physiotherapy and lifestyle modification, oral or injectable DMTs of varying intensity, or newer monoclonal antibody infusions, depending on disease severity and patient preference. AHSCT is typically considered only after other DMTs have failed.

What we need to prepare a formal estimate

Share whatever you have — the care team will confirm the final checklist after reviewing your case.

Reports required

  • Recent brain and spinal cord MRI reports with contrast
  • Neurologist's clinical notes and MS subtype diagnosis
  • History of relapses and EDSS disability score
  • List of current and previously tried DMT medications
  • Recent blood work (CBC, liver/kidney function, JC virus status)
  • Evoked potential or lumbar puncture (CSF) results if performed
  • Any prior hospitalization or relapse treatment records

Patient information needed

  • Current mobility status and use of walking aids
  • Presence of bladder, bowel, or cognitive symptoms
  • Any comorbid autoimmune or cardiac conditions
  • Allergy history, especially to steroids or immunotherapy drugs
  • Vaccination history and current infection status
  • Pregnancy status or family planning intentions
  • Availability of a caregiver/companion during travel

Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.

Want a formal estimate?

Share your reports and patient information so our care coordination team can review your case.

How this directory is built

Doctors are matched using the specialty, location, condition (Multiple Sclerosis (MS) Management) and procedure (Multiple Sclerosis (MS) Management) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.

Need help with the next step?

Share your needs with our care coordination team for information about doctors and hospitals.

Common questions

FAQs about Multiple Sclerosis (MS) Management in Mumbai, India

What is Multiple Sclerosis (MS)?
Multiple sclerosis (MS) is a long-term autoimmune condition in which the body's immune system mistakenly attacks the protective myelin coating around nerve fibres in the brain and spinal cord, impairing nerve signal transmission. It can follow different clinical courses, most commonly a relapsing-remitting pattern, but may also be progressive from onset or over time.
What are the symptoms and health risks of Multiple Sclerosis (MS)?
People with MS may experience a broad spectrum of symptoms including visual disturbances (such as optic neuritis), limb weakness or numbness, balance and coordination problems, spasticity, bladder dysfunction, fatigue, and difficulties with memory or concentration. Symptoms can vary considerably between individuals and may fluctuate — improving, worsening, or accumulating depending on disease course and activity. Experiencing any of these symptoms does not by itself confirm a diagnosis of MS, and a formal clinical evaluation is necessary to distinguish MS from other neurological conditions.
How is Multiple Sclerosis (MS) diagnosed?
Diagnosis of MS is typically guided by the McDonald Criteria, which integrate clinical findings with MRI evidence of lesions disseminated in space and time within the central nervous system. A neurologist will take a detailed history of symptom episodes, perform a full neurological examination, and usually request brain and spinal cord MRI scans, often with and without contrast, to identify characteristic plaques. Additional investigations such as cerebrospinal fluid (CSF) analysis for oligoclonal bands, visual evoked potentials (VEPs), and blood tests to exclude other conditions may also be used, with the overall pattern — rather than any single result — informing the diagnosis and classification of MS subtype (e.g. relapsing-remitting, secondary progressive, primary progressive).
How is Multiple Sclerosis (MS) treated?
Treatment for MS is highly individualised and is guided by disease subtype, relapse frequency, severity of disability (often tracked using the Expanded Disability Status Scale, or EDSS), and MRI activity. Non-procedural approaches form the cornerstone of management for most patients and include disease-modifying therapies (DMTs) to reduce relapse rates and slow progression, as well as symptom-specific medications and rehabilitation. In selected cases where conventional DMTs have not provided adequate disease control, more intensive procedural interventions — such as haematopoietic stem cell transplantation (HSCT) — may be considered, always within the context of a specialist multidisciplinary team and individual risk-benefit assessment.
Can Multiple Sclerosis (MS) be treated without a procedure?
The primary management pathway for MS is non-surgical. Disease-modifying therapies (DMTs) — ranging from first-line oral or injectable agents to higher-efficacy infusion-based treatments — are used to suppress immune activity, reduce relapses, and limit new lesion formation. Complementary non-pharmacological support including physiotherapy, occupational therapy, cognitive rehabilitation, psychological support, and lifestyle measures (regular exercise, smoking cessation, vitamin D optimisation) play an important role alongside medication in maintaining quality of life and function.
When is Multiple Sclerosis (MS) Management considered for Multiple Sclerosis (MS)?
Multiple Sclerosis (MS) Management may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Multiple Sclerosis (MS)?
MS is evaluated and managed primarily by a neurologist with specialist expertise in demyelinating diseases or neuroimmunology; many centres operate dedicated MS clinics where neurologists work alongside MS specialist nurses, physiotherapists, and other allied health professionals. In cases where advanced intervention such as stem cell therapy is being considered, a haematologist with experience in HSCT for neurological conditions may also be involved.
How do I choose a doctor for Multiple Sclerosis (MS)?
When selecting a specialist or centre for MS care, it is worth comparing the neurologist's experience specifically with MS and the range of DMTs they routinely prescribe, including access to higher-efficacy therapies, as well as the availability of a multidisciplinary MS team, MRI facilities, and structured long-term follow-up and monitoring protocols.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.